Efficacy of the combination of venetoclax and hypomethylating agents in the treatment of patients with primary, relapsed and/or refractory acute myeloid leukemia

Relevance and goals. Treatment of patients with acute myeloid leukemia has traditionally been highly intensive and includes induction therapy using cytarabine and anathracyclines. In addition to new opportunities in the treatment of acute myeloid leukemia, the problem of toxicity of high-intensity t...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	E. V. Usikova, K. D. Kaplanov, V. I. Vorob'ev, T. I. Lobanova, M. A. Ul'yanova, D. G. Kisilichina, Yu. N. Kobzev, D. I. Shikhbabaeva, O. Yu. Vinogradova, V. V. Ptushkin
Μορφή:	Artigo
Γλώσσα:	Russo
Έκδοση:	Private institution educational organization of higher education "Medical University "ReaViz" 2023-01-01
Σειρά:	Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье
Θέματα:	acute myeloid leukemia hypomethylating agents venetoclax efficacy and overall survival analysis hematological toxicity infectious complications covid-19
Διαθέσιμο Online:	https://vestnik.reaviz.ru/jour/article/view/565
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!